Optimizing diastolic filling by pacing in nonobstructive hypertrophic cardiomyopathy

Muthiah Subramanian1, Vijay Shekar1, Preetam Krishnamurthy1

  • 1Department of Cardiology, AIG Institute of Cardiac Sciences and Research, Hyderabad, India.

Heart Rhythm
|May 20, 2023
PubMed

Insights

Optimized sequential atrioventricular (AV) pacing from the right ventricular apex (RVA) improved diastolic function and functional capacity in patients with nonobstructive hypertrophic cardiomyopathy (nHCM). This pacing strategy offers a new treatment option for nHCM patients.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Cardiovascular Imaging

Background:

  • Limited treatment options exist for symptomatic patients with nonobstructive hypertrophic cardiomyopathy (nHCM).
  • Diastolic dysfunction is a key feature of nHCM, impacting functional capacity.

Purpose of the Study:

  • To evaluate the impact of sequential atrioventricular (AV) pacing from various right ventricular (RV) sites and AV delays on diastolic function and functional capacity in nHCM patients.
  • To identify optimal pacing parameters for improving cardiac function in nHCM.

Main Methods:

  • Prospective enrollment of 21 symptomatic nHCM patients with preserved left ventricular (LV) systolic function.
  • Echocardiographic assessment of diastolic function during dual-chamber pacing at different RV sites (apex, midseptum, outflow tract) and AV delays.
  • Identification of optimal pacing site and AV delay based on diastolic filling parameters and E/e' ratio.

Main Results:

  • RV apex (RVA) pacing at an optimized AV delay significantly improved diastolic function (E/e') in 18 of 21 patients (responders).
  • Responders achieved optimal diastolic filling with RVA pacing at sensed AV delays (SAVD) of 130-160 ms.
  • Non-responders exhibited longer symptom duration, lower LV ejection fraction, and higher late gadolinium enhancement burden.
  • During follow-up, responders showed significant improvements in diastolic function, functional capacity (NYHA class), and N-terminal pro-brain natriuretic peptide levels.

Conclusions:

  • Sequential AV pacing from the RVA with an optimized AV delay is an effective strategy for improving diastolic function and functional capacity in a subset of nHCM patients.
  • This pacing approach represents a promising therapeutic option for managing symptomatic nHCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
19
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
17
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16